Page last updated: 2024-08-26

fibrinogen and Genetic Predisposition

fibrinogen has been researched along with Genetic Predisposition in 220 studies

Research

Studies (220)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.45)18.7374
1990's9 (4.09)18.2507
2000's104 (47.27)29.6817
2010's90 (40.91)24.3611
2020's16 (7.27)2.80

Authors

AuthorsStudies
Abbadessa, G; Armetta, I; Bonavita, S; D'Elia, G; Di Pietro, A; Lavorgna, L; Lus, G; Miele, G; Palladino, R; Signoriello, E; Sparaco, M; Trojsi, F1
Ceznerová, E; Kaufmanová, J; Kotlín, R; Loužil, J; Sovová, Ž; Štikarová, J; Suttnar, J1
Fang, Y; Gao, N; Guo, Y; Li, GF; Qiao, H; Wang, C; Wang, T; Wen, Q; Xu, C; Yang, L; Zhang, Y; Zhou, J1
Atkinson, J; Hu, Z; Huan, T; Java, A; Pozzi, N; Schroeder, MC; Seddon, JM1
Geng, C; Gu, R; Wang, C; Wang, H; Wang, J; Zhu, Z1
Asselta, R; Caccia, S; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Stasko, J; Zolkova, J1
Casini, A; Undas, A1
Li, Q; Liu, W; Sun, Y; Zhang, B1
Duan, Q; Hong, C; Lu, Q; Luo, T; Lv, J; Shu, S; Zhang, Q; Zhao, D; Zhao, W1
Bakker, B; Blom, AM; de Breuk, A; de Jong, EK; de Jong, S; den Hollander, AI; Hoyng, CB; Nilsson, SC; van den Heuvel, LP; van der Kar, NCAJ; Volokhina, EB1
Ahmadi, A; Baghaipour, MR; Dorgalaleh, A; Ghasemi, JB; Jazebi, M; Rezaei Makhouri, F; Rezvani, MR; Safa, M; Tabibian, S; Tavasoli, B; Zaker, F1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Auger, I; Balandraud, N; Roudier, J1
Cruz-Flores, S; Cushman, M; Kamin Mukaz, D; McCullough, LD; Zakai, NA1
Dounavi, ME; Low, A; Mak, E; Markus, HS; Muniz-Terrera, G; O'Brien, JT; Ritchie, CW; Ritchie, K; Stefaniak, JD; Su, L1
Bánovčin, P; Grendár, M; Kolková, Z; Kostková, M; Motyková, K; Suroviaková, S; Vojtková, J1
Hong, WJ; Jiang, YQ; Li, WL; Luo, S; Ni, H; Wang, WF; Wang, XW; Wu, LN; Zheng, HB; Zhu, F1
Chauhan, AK; Chorawala, MR; Dhanesha, N; Doddapattar, P; Kokame, K; Lentz, SR; Nayak, MK; Staber, JM1
Kutlu, G; Sirin, B; Yılmaz, M; Yılmaz, N; Yılmaztekin, S1
Brennan, S; Brennan, SO; Laurie, AD1
Braekkan, SK; Frazer, KA; Hansen, JB; Hindberg, K; Horvei, LD; Rosendaal, FR; Smith, EN; Solomon, T1
Arai, S; Matsuda, K; Okumura, N; Sugano, M; Taira, C; Uehara, T1
Li, ZG; Liu, G; Wu, HW1
Chen, L; Hu, X; Huang, J; Li, Y; Qiao, S; Wang, J; Wu, J; Xu, S1
Fidalgo, T; Manco, L; Martinho, P; Ribeiro, ML; Sarmento, AB; Silva, C1
Bi, P; Dong, Y; Guo, Y; Jiang, A; Li, X; Luo, H; Zhang, B1
Braekkan, SK; Evensen, LH; Gabrielsen, ME; Hansen, JB; Hveem, K; Mathiesen, EB; Morelli, VM; Njølstad, I; Rinde, LB; Rosendaal, FR; Småbrekke, B1
Petrovič, D1
Guo, J; He, G; He, L; Lei, L; Lu, Q; Wang, Y; Xiao, J; Xu, Y; Yin, Y; Yu, L; Zhang, J; Zhao, J1
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T1
Chaparzadeh, N; Farzadi, L; Ghasemzadeh, A; Ghorbian, S; Kafshdooz, T; Poursadegh Zonouzi, A; Sadaghiani, MM; Sakhinia, E; Sakhinia, M1
Grover, A; Kumar, A; Kumar, P; Prasad, K; Sagar, R; Sahu, JK; Srivastava, AK; Vivekanandhan, S1
Bang, HJ; Choi, KS; Chung, JH; Kang, H; Kim, SK; Kim, SY; Kwack, K; Lee, SK; Nam, M; Ro, M; Won, S; Yang, JW1
Bakirci, EM; Borekci, A; Kalkan, K; Karakoyun, S; Sevimli, S; Topcu, S; Vançelik, S1
Atamaniuk, J; Dossenbach-Glaninger, A; Oberkanins, C; van Trotsenburg, M1
Algarni, KD; Cohen, EA; Deb, S; Desai, ND; Dubbin, JD; Elituv, R; Fremes, SE; Liu, PP; McManus, BM; Radhakrishnan, S; Rajamani, K; Schwartz, L; Singh, SK; Vincent, J; Yanagawa, B1
Gu, L; Guo, X; Huang, G; Liang, B; Long, J; Su, L; Tan, J; Wu, G; Yan, Y1
Gu, L; Huang, G; Liang, B; Liu, W; Su, L; Tan, J; Wu, G; Yan, Y1
Chen, QL; Hu, XF; Jin, XP; Li, C; Li, WL; Wang, F; Wang, WF; Zheng, Z; Zhu, F; Zhu, M1
Biswas, A; Ivaskevicius, V; Oldenburg, J; Thomas, A1
Kopyta, I; Sarecka-Hujar, B; Sordyl, J; Sordyl, R1
Anaya, JM; Arango-Guerrero, MT; Chua, KH; Ghosh, K; Harley, JB; Kim-Howard, X; Looger, LL; Maiti, AK; Motghare, P; Nath, SK; Niewold, TB; Pradhan, V; Sun, C1
Chang, L; Li, HH; Tao, SB; Yan, HQ; Yuan, B; Zhang, LJ; Zhao, JH1
Dardiotis, E; Dziedzic, T; Fountas, K; Gąsowski, J; Golenia, A; Hadjigeorgiou, G; Jagiełła, J; Klimkowicz-Mrowiec, A; Paterakis, K; Pera, J; Słowik, A; Wnuk, M1
Arai, S; Fujikawa, Y; Hiroshima, Y; Ichikawa, N; Kirihara, T; Kobayashi, H; Kurihara, T; Okumura, N; Sato, K; Soya, K; Sumi, M; Takeda, W; Ueki, T; Ueno, M1
Erkinjuntti, T; Karhunen, PJ; Kaste, M; Martiskainen, M; Oksala, A; Oksala, N; Pohjasvaara, T1
Brennan, SO; Laurie, A1
Bauduer, F1
Ababneh, OH; Abu-Ameerh, MA; Al-Khateeb, MA; Albdour, MD; Awidi, AS; Awidi, MA; Bener, A; Dweik, MR; Gharaibeh, AM; Saleh, MM1
Banz, V; Candinas, D; Demarmels Biasiutti, F; Fort, A; Furer, C; Keogh, A; Kühni-Boghenbor, K; Lämmle, B; Neerman-Arbez, M; Stoffel, MH; Stroka, D; Vu, D1
Chen, XY; Cheng, SY; Wang, RD; Zeng, JW; Zhao, YD1
Afrasiabi, A; Asselta, R; Borhany, M; Duga, S; Guella, I; Menegatti, M; Peyvandi, F; Platè, M; Robusto, M; Shamsi, T; Soldà, G1
Bojiang, L; Li, J; Tong, L; Wenjin, P; Xiaomin, H; Xin, L; Yingwu, L; Yu, W; Yunyun, W1
Brennan, SO; Laurie, A; Smith, M1
Shchukin, SP1
Luo, TY; Zhang, XF1
Harris, CL; Heurich, M; Llorca, O; López-Perrote, A; López-Trascasa, M; Martínez-Barricarte, R; Morgan, BP; Pinto, S; Rodríguez de Córdoba, S; Sánchez-Corral, P; Tortajada, A1
Cai, H; Cai, Y; Chen, Z; Qi, H; Tan, L; Wu, G1
Asselta, R; Braidotti, P; Caccia, S; D'Antiga, L; Duga, S; Maggiore, G; Nastasio, S; Perisic, VN; Peyvandi, F; Robusto, M1
Acosta, D; Caldés, T; de la Hoya, M; de Las Heras, N; Díaz-Millán, I; Díaz-Rubio, E; Lahera, V; López Farré, A; Melander, O; Modrego, J; Perez-Segura, P; Rico Zalba, LA; Santos-Sancho, JM; Zamorano-León, JJ1
Biswas, A; Griesmacher, A; Hohenstein, K; Ivaškevičius, V; Oldenburg, J; Weigel, G; Würtinger, P; Zehetbauer, S1
Bergh, E; Forman, EJ; Franasiak, JM; Lonczak, A; Patounakis, G; Scott, RT; Tao, X; Treff, N1
Chen, WM; Coull, B; Dupuis, J; Dzhivhuho, G; Furie, KL; Gogarten, SM; Hsu, FC; Keene, KL; Lin, H; Madden, EB; Malik, R; Mehndiratta, P; Nelson, S; Rich, SS; Rowles, JL; Sale, MM; Seshadri, S; Southerland, AM; Williams, SR; Worrall, BB1
Erdem, HB; Eroz, R; Ozdemir, G; Ozel, L; Sahin, I; Tasdemir, S; Tatar, A1
Ding, SF; Jiang, QJ; Jin, Y; Qiu, CG; Zheng, QS1
Jin, YH; Liu, MN; Shen, XL; Wang, MS; Xu, XM; Zhao, ZS; Zheng, JY1
Biswas, A; Davoli, M; Detarsio, G; Gupta, S; Ivaškevičius, V; Oldenburg, J; Pérez, S; Quartara, A; Raviola, M; Rühl, H1
Alessandrini, F; Brandimarti, F; Catalani, C; De Angelis, L; Galeazzi, R; Gesuita, R; Giorgetti, R; Giovagnetti, S; Pesaresi, M; Righi, E; Tagliabracci, A1
Liu, R; Ma, Y; Rao, W; Shi, J; Su, Y; Yang, G; Yu, Q; Yu, Y; Zhang, H; Zhang, S; Zhou, N1
Brungs, T; Casini, A; de Moerloose, P; Lavenu-Bombled, C; Neerman-Arbez, M; Vilar, R1
Gijbels, MJJ; Heestermans, M; Ouweneel, AB; Reitsma, PH; Van Eck, M; van Vlijmen, BJM; Verwilligen, RAF1
Li, J; Liu, L; Sheng, W; Xu, X1
Favorova, OO; Gusev, EI; Martynov, MIu; Nikonova, AA; Parfenov, MG; Serdiuk, IE; Sudomoina, MA1
Benachi, A; Blouin, J; Dürrbach, A; Fakhouri, F; Frémeaux-Bacchi, V; Grünfeld, JP; Hourmant, M; Jablonski, M; Knebelmann, B; Lepercq, J; Pirson, Y1
Bos, MJ; Breteler, MM; Cheung, EY; de Maat, MP; Hofman, A; Koudstaal, PJ; Leebeek, FW1
Almasy, L; Best, LG; Cole, S; Diego, VP; Goring, H; Haack, K; Laston, S; Lee, ET; Li, X; MacCluer, J; North, KE; Palmieri, V; Tracy, RP; Umans, JG1
Chen, J; Chen, W; Chen, X; Jin, L; Xu, M1
Baldari, F; Bellander, T; Breitner, S; Chrysohoou, C; Greven, S; Heid, IM; Illig, T; Jacquemin, B; Koenig, W; Lanki, T; Nyberg, F; Pekkanen, J; Peters, A; Pistelli, R; Rückerl, R; Schneider, A; Stefanadis, C; Sunyer, J; Wichmann, HE1
Bové, A; Cervera, R; de la Red, G; Espinosa, G; Monteagudo, J; Plaza, J; Reverter, JC; Tàssies, D1
Baumert, J; Döring, A; Gohlke, H; Grallert, H; Illig, T; Koenig, W; Kolz, M; Peters, A; Wichmann, HE1
Kazakevich, EV; Serdechnaia, EV; Tatarskiĭ, BA1
Baccarelli, A1
Favorova, OO; Gusev, EI; Iasamanova, AN; Kolesnikova, TI; Martynov, MIu; Nikonova, AA; Parfenov, MG; Serdiuk, IE; Sudomoina, MA1
Dahl, M; Nordestgaard, BG1
Guo, X; Zhang, D; Zhang, X1
Lacolley, P; Regnault, V; Safar, ME1
Gohil, R; Peck, G; Sharma, P1
Aggermann, T; Binder, S; Frantal, S; Haas, P; Krugluger, W; Oberkanins, C; Pühringer, H; Steindl, K1
Cetin, A; Cetin, M; Kocak, N; Ozdemir, O; Ozen, F; Yenicesu, C; Yenicesu, GI; Yildiz, C1
Bielinski, SJ; Carlson, CS; Fornage, M; Gross, MD; Jacobs, DR; Jenny, NS; Lange, LA; Nickerson, DA; Reiner, AP; Tracy, RP; Walston, J; Williams, OD1
Carty, CL; Cushman, M; Heagerty, P; Heckbert, SR; Jarvik, GP; Lange, LA; Reiner, AP; Tracy, RP1
Cherny, SS; Cheung, BM; Jiang, CQ; Lam, KS; Lam, TH; Ong, KL; Sham, PC; Thomas, GN; Tso, AW1
Feldmann, M; Fisher, B; Kinloch, A; Lundberg, K; Malmström, V; Venables, PJ; Wegner, N1
Barbieri, M; Boccardi, V; Esposito, A; Marfella, R; Paolisso, G; Papa, M; Portoghese, M; Rizzo, MR1
Bukowska, H; Chełstowski, K; Honczarenko, K; Jastrzębska, M; Kozłowska-Wojciechowska, M; Makarewicz-Wujec, M; Masztalewicz, M; Mierzecki, A1
Dong, RZ; Gong, JE; Gu, WP; Liang, J; Song, XM; Tang, CL; Xiao, H; Yang, QD1
Gao, J; Wang, HY; Wu, NJ; Zhang, SH1
Brennan, SO; Conard, K; Davis, RL; Furuya, KN; Savo, A1
Chen, Z; Hinohara, K; Inoue, Y; Kasahara, Y; Kimura, A; Nakajima, T; Sakao, S; Tanabe, N; Tatsumi, K1
Biron-Andréani, C; Boulot, P; de Moerloose, P; Fish, RJ; Nagaswami, C; Neerman-Arbez, M; Reyftmann, L; Vorjohann, S; Weisel, JW1
Brennan, SO; Davis, RL1
Delaney, JA; Folsom, AR; Green, D; Ho, LA; Jacobs, DR; Johnson, AD; Keating, BJ; Lange, EM; Lange, LA; Li, Y; O'Donnell, CJ; Palmer, C; Redline, S; Reiner, AP; Smith, NL; Tang, W; Taylor, HA; Taylor, KC; Tofler, G; Tracy, RP; Wassel, CL; Wilson, JG; Yang, Q1
Ashavaid, TF; Dalal, JJ; Kondkar, AA; Nair, KG; Ponde, CK; Rajani, R; Shalia, KK; Todur, SP1
Brennan, SO; Davis, RL; Oliver, J1
Buggage, R; Chakravarthy, U; Evans, C; Fletcher, A; Mitchell, P; Piault, E; Pleil, A; Wong, TY; Zlateva, G1
Ay, C; Dunkler, D; Horvath, B; Mannhalter, C; Pabinger, I; Pabinger, M; Quehenberger, P; Tiedje, V; Zielinski, C1
Hamsten, A; Joutsi-Korhonen, L; Kaprio, J; Kaye, SM; Kotronen, A; Lassila, R; Pietiläinen, KH; Rissanen, A; Silveira, A; Yki-Järvinen, H1
Caulfield, MJ; Kiechl, S; Morris, GE; Motterle, A; Pender, SL; Willeit, J; Xiao, Q; Ye, S1
Du, X; Hu, Z; Liu, B; Liu, Y; Ma, M; Xia, J; Xu, H; Yang, Q; Zeng, Y; Zhang, L1
Drenos, F; Humphries, SE; Ken-Dror, G; Kivimaki, M; Kumari, M1
Dimitroulas, T; Douglas, KM; Kitas, GD; Panoulas, VF; Smith, J1
Doğan, A; Erdogan, D; Icli, A; Varol, E1
Anuurad, E; Berglund, L; Enkhmaa, B; Gungor, Z; Kim, K; Zhang, W1
Alfredsson, L; Bengtsson, C; Holmdahl, R; Israelsson, L; Jiang, X; Kallberg, H; Kessel, C; Kharlamova, N; Klareskog, L; Lundberg, K; Padyukov, L; Pollak-Dorocic, I; Reed, E1
Chegodaev, DA; Kovtun, OP; L'vova, OA1
Hellmann, A; Mital, A; Neerman-Arbez, M; Undas, A1
Chu, JY; Huang, XQ; Li, JM; Lin, KQ; Qi, L; Sun, H; Yang, ZQ1
Adamo, EB; Alibrandi, A; Altavilla, D; Atteritano, M; Bitto, A; Caccamo, D; Currò, M; D'Anna, R; Ferlazzo, N; Ientile, R; Marini, H; Polito, F; Squadrito, F1
Bova, M; Caruso, C; Caruso, M; Forte, GI; Lio, D; Massenti, MF; Novo, S; Palmeri, M; Scola, L; Vaccarino, L; Vitale, F; Vitale, S1
Adam, F; Berrou, E; Bryckaert, M; Coupry, I; Favier, R; Fergelot, P; Goizet, C; Jandrot-Perrus, M; Kauskot, A; Lebret, M; Nurden, A; Nurden, P; Rosa, JP1
Agustí, A; Bakke, P; Beaty, TH; Celli, B; Cho, MH; Coxson, H; Crapo, JD; Gulsvik, A; Hersh, CP; Kim, DK; Kong, X; Litonjua, A; Lomas, DA; MacNee, W; Miller, BE; Qiu, W; Rennard, S; Riley, JH; Silverman, EK; Tal-Singer, R; Vestbo, J; Wouters, E; Yates, JC1
Baeten, D; Cantaert, T; Tak, PP; Teitsma, C1
Brennan, SO; Ho, LL; Zebeljan, D1
Berlit, P; Harbrecht, U; Klockgether, T; Kraus, JA; Müller, J; Nahser, HC; Stüper, BK1
Heinonen, S; Hiltunen, M; Laasanen, J; Mannermaa, A; Punnonen, K1
Sehnal, E; Slany, J1
Grant, P; Mansfield, M; Mills, J1
Chełstowski, K; Foltynska, A; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B1
Asselta, R; Duga, S; Malcovati, M; Peyvandi, F; Spena, S; Tenchini, ML1
van der Bom, JG1
Cichocki, L; Forjanics, A; Gasser, R; Köppel, H; Pilger, E; Renner, W1
Baretton, G; Carmeliet, P; Castellino, F; Erlich, J; Fernandes, A; Gutstein, D; Kehrle, B; Luther, T; Mackman, N; Melis, E; Parry, G; Pawlinski, R; Pedersen, B; Pyo, R; Rosen, E; Taubman, M; Zhang, J1
De Staercke, C; Hooper, WC1
Abu-Libdeh, B; Bouchardy, I; Morris, MA; Neerman-Arbez, M; Vu, D1
Erkinjuntti, T; Ilveskoski, E; Karhunen, PJ; Kaste, M; Kunnas, T; Laippala, P; Mäntylä, R; Martiskainen, M; Mikkelsson, J; Pohjasvaara, T1
Cupples, LA; D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; O'Donnell, CJ; Tofler, GH; Yang, Q1
Bickel, C; Blankenberg, S; Cambien, F; Georges, JL; Hafner, G; Meyer, J; Nicaud, V; Poirier, O; Rupprecht, HJ; Tiret, L1
Watzke, HH1
Goracy, I; Jastrzebska, M; Naruszewicz, M1
Dossenbach-Glaninger, A; Finsterer, J; Hopmeier, P; Krugluger, W; Stöllberger, C1
Davey Smith, G; Ebrahim, S; Harbord, R1
Camilleri, RS; Cohen, H; Everington, T; Peebles, D; Portmann, C1
Bi, S; Li, G; Pan, S; Wang, D; Wen, S1
Alte, D; Felix, SB; John, U; Robinson, DM; Schwahn, C; Völzke, H1
Corral, J; del Rey, ML; González-Conejero, R; Lip, GY; Marín, F; Roldán, V; Sogorb, F; Vicente, V1
Antoniades, C; Brown, M; Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C1
Chudakova, DA; Minushkina, LO; Nosik, VV; Zateĭshchikov, DA1
Aillaud, MF; di Minno, G; Eriksson, P; Hamsten, A; Hawe, E; Humphries, S; Juhan-Vague, I; Mannila, MN; Margaglione, M; Mussoni, L; Silveira, A; Tremoli, E; Yudkin, J1
Chetstowski, K; Ciechanowicz, A; Foltynska, A; Goracy, I; Janczak-Bazan, A; Jastrzebskal, M; Naruszewicz, M; Wesotowska, T; Widecka, K1
Kirbis, J; Milutinović, A; Poglajen, G1
Almasy, L; Blangero, J; Buil, A; Fontcuberta, J; Lathrop, M; Soria, JM; Souto, JC1
Ijzerman, RG1
Broom, I; McNeill, G; Mutch, WJ; Tuya, C1
Berthier-Schaad, Y; Coresh, J; Fallin, MD; Fink, NE; Klag, MJ; Liu, Y; Smith, MW; Tracy, RP1
Ebrahim, S; Harbord, R; Milton, J; Smith, GD; Sterne, JA1
Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Millo, B; Torbus-Lisiecka, B1
Gao, J; Li, HF; Pei, HZ; Wang, SJ; Yuan, XD1
Ginsburg, D1
Chang, CJ; Hsu, LA; Hsu, TS; Ko, YL; Lee, YS; Teng, MS; Tsai, CT; Wu, S1
Friedlander, Y; Kark, JD; Sinnreich, R; Siscovick, DS; Tracy, RP1
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R1
Ericsson, CG; Eriksson, P; Hamsten, A; Mannila, MN; Silveira, A1
Brennan, SO; Lowen, R; Matsunaga, A; Mosesson, MW; Siebenlist, KR1
Ma, AJ; Pan, XD; Xing, Y; Zhang, CS; Zhang, YN1
Camargo, AL; Gabriel, SB; Hirschhorn, JN; Kathiresan, S; Larson, MG; O'Donnell, CJ; Tofler, GH; Yang, Q1
Smith, GD1
Marie, B; Maumus, S; Siest, G; Vincent-Viry, M; Visvikis-Siest, S1
Boerwinkle, E; Carlson, CS; Carty, CL; Fornage, M; Jaquish, CE; Lewis, CE; Nickerson, DA; Reiner, AP; Rice, K; Rieder, MJ; Siscovick, DS; Smith, JD; Tracy, RP; Wan, JY; Williams, OD1
Liu, YM; Mao, YL; Pang, BS; Wang, C; Xiao, B; Yang, YH; Zhai, ZG1
Cai, WW; Chen, XD; Cheng, S; Huang, SX; Liang, L; Liao, XP; Liu, GX; Long, ZG; Sun, C; Tang, XL; Wang, XY; Wen, GQ; Xiao, F1
De Stavola, BL; Humphries, SE; Meade, TW1
Dörner, T; Hoppe, B; Kiesewetter, H; Salama, A; Tolou, F1
Blouin, J; Fakhouri, F; Frémeaux-Bacchi, V; Grünfeld, JP; Knebelmann, B; Lequintrec, M; Lesavre, P; Noël, LH; Salomon, R; Servais, A1
Boguch, JM; Carlson, CS; Duan, H; Hatsukami, TS; Heagerty, PJ; Jarvik, GP; Nickerson, DA; Nord, AS; Pritchard, DK; Ranchalis, J; Rieder, MJ; Schwartz, SM1
Eriksson, P; Farrell, DH; Hamsten, A; Kazmierczak, SC; Lovely, RS; Mannila, MN; Samnegård, A; Silveira, A1
de Maat, MP; Hofman, A; Kardys, I; Uitterlinden, AG; Witteman, JC1
Bertina, RM; de Visser, MC; Houwing-Duistermaat, JJ; Rosendaal, FR; van Minkelen, R; Vos, HL1
Grünbacher, G; Köppel, H; Marx-Neuhold, E; März, W; Pilger, E; Renner, W; Wascher, T; Weger, W1
Gong, R; Li, L; Liu, Z1
Alberti, C; Boudailliez, B; Bouissou, F; Deschenes, G; Dragon-Durey, MA; Fischbach, M; Fremeaux-Bacchi, V; Gie, S; Guest, G; Loirat, C; Macher, MA; Morin, D; Niaudet, P; Nivet, H; Sellier-Leclerc, AL; Tsimaratos, M1
Chen, WQ; Chen, XC; Han, CL; Xu, MT; Zhou, W1
Bachoo, P; Brittenden, J; Croal, B; Ford, I; Greaves, M; Hillis, GS; Rajagopalan, S1
Chevreaud, C; de Mazancourt, P; French, P; Hanss, M; Négrier, C1
Carter, AM; Cymbalista, CM; Grant, PJ; Spector, TD1
Galanakis, DK; Henschen, A; Hubbs, D; Nagaswami, C; Neerman-Arbez, M; Scheiner, T; Weisel, JW1
Allaart, CF; Breedveld, FC; Cheung, K; de Vries, RR; de Vries-Bouwstra, JK; Drijfhout, JW; Huizinga, TW; Ioan-Facsinay, A; Pruijn, GJ; Toes, RE; van der Helm-van Mil, AH; Verpoort, KN1
Dudbridge, F; Eikenboom, JC; Goldsmith, K; Long, L; Morrell, NW; Pepke-Zaba, J; Suntharalingam, J; Toshner, MR; Treacy, CM; van Marion, V1
Ozgen, AG; Saraç, F; Tüzün, M; Yilmaz, C1
Archetti, S; Assanelli, D; Grassi, M; Kisialiou, A; Mozzini, C; Pezzini, A1
Carlson, CS; Carty, CL; Cushman, M; Durda, JP; Hindorff, LA; Jenny, NS; Jones, D; Lange, LA; Nickerson, D; Reiner, AP; Rice, K; Tracy, RP; Walston, J1
Chae, JS; Choi, D; Heo, YM; Huttner, K; Hyun, YJ; Jang, Y; Kim, OY; Koh, SJ; Lee, JH; Shin, DJ1
Doggen, CJ; Rosendaal, FR; van der Bom, JG; van der Krabben, MD1
Dash, D; John, S; Kakkar, VV; Maitra, A; Ramanna, JK; Rao, VS; Sannappa, PR; Shanker, J1
Bergner, R; Eriksson, M; Hegenbart, U; Lohse, P; Röcken, C; Schmidt, H; Schönland, S1
Folsom, AR; Greenberg, B; Harada, S; Iida, M; Iso, H; Koike, K; Komachi, Y; Sato, S; Shimamoto, T; Winkelmann, JC1
Assmann, G; Funke, H; Heinrich, J; Köhler, E; Rust, S; Schönfeld, R; Schulte, H1
Cappucci, G; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Pirro, L; Vecchione, G1
Avenirova, EA; Ivanov, SN; Liberman, IS; Vinogradova, TV1
Carter, AM; Catto, AJ; Grant, PJ1
D'Orazio, A; De Lucia, D; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Negrini, R; Zito, F1
Chan, LC; Janus, ED; Lam, KS; Ma, OC; Wat, NM1
Cloutier, G; Genest, J; Weng, X1
Grant, PJ; Lane, DA1
Byzova, TV; Plow, EF1
Bray, PF; Goldschmidt-Clermont, PJ; Roos, C; Vijayan, KV1
Austin, H; Dilley, A; Ellingsen, D; Evatt, B; Hooper, WC; Lally, C; Rawlins, P; Silva, V; Wenger, NK; Wideman, C1
Aston, CE; Kamboh, MI; Low, PS; Saha, N1
Bønaa, KH; Joakimsen, O; Stensland-Bugge, E1
Amadei, N; Baracho, GV; Bastos, W; Florido, MP; Isaac, L; Nudelman, V1
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Mittleman, M; Muller, JE; O'Donnell, CJ; Sutherland, PA; Tofler, GH1
Brennan, SO; Callea, F; Fabbretti, G; George, PM; Kudryk, B; Medicina, D1
Halonen, P; Kareinen, A; Laakso, M; Lehto, S; Viitanen, L1
Humphries, SE; Montgomery, HE; Talmud, PJ1
Heng, CK; Hong, S; Liu, Y; Low, PS; Saha, N1
Benedetta Donati, M; Iacoviello, L; Vischetti, M; Zito, F1
Blumenthal, RS; Braunstein, JB; Bray, P; Gerstenblith, G; Kershner, DW; Post, WS; Schulman, SP1
Flavell, DM; Hawe, E; Humphries, SE; Jamshidi, Y; MacCallum, PK; Meade, TW1
Bukowska, H; Chelstowski, K; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B1
Brennan, PJ; Cruickshank, JK; Dawson, SJ; Green, FR; Hamsten, A; Henney, AM; Kelleher, CH; Lane, A; Thomas, AE; Wilkes, HC1
Comp, PC1

Reviews

31 review(s) available for fibrinogen and Genetic Predisposition

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.
    Stroke, 2020, Volume: 51, Issue:11

    Topics: Biomarkers; Black or African American; Blood Coagulation; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Predisposition to Disease; Health Status Disparities; Humans; Incidence; Inflammation; Interleukin-6; Lipoprotein(a); Protein C; Risk Factors; Sickle Cell Trait; Stroke; United States

2020
Associations of β-Fibrinogen Polymorphisms with the Risk of Ischemic Stroke: A Meta-analysis.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:2

    Topics: Asian People; Brain Ischemia; Case-Control Studies; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Phenotype; Polymorphism, Genetic; Risk Factors; Stroke; White People

2019
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
    Circulation, 2013, Sep-17, Volume: 128, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult

2013
Genetic polymorphism of β-fibrinogen gene-455G/A can contribute to the risk of ischemic stroke.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:2

    Topics: Age Factors; Alleles; Asian People; Brain Ischemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Models, Genetic; Odds Ratio; Polymorphism, Genetic; Publication Bias; Risk Factors; Stroke; White People

2014
Influence of the β-fibrinogen-455G/A polymorphism on development of ischemic stroke and coronary heart disease.
    Thrombosis research, 2014, Volume: 133, Issue:6

    Topics: Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment; Stroke

2014
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
    Hamostaseologie, 2014, Volume: 34, Issue:2

    Topics: Blood Transfusion; Factor VIII; Factor XIII; Factor XIII Deficiency; Fibrinogen; Genetic Predisposition to Disease; Humans

2014
The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.
    Molecular biology reports, 2014, Volume: 41, Issue:7

    Topics: Adult; Blood Coagulation Factors; Blood Vessels; Brain Ischemia; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Incidence; Male; Polymorphism, Genetic; Risk Factors; Stroke

2014
FGB gene - 148C>T polymorphism is associated with increased risk of ischemic stroke in a Chinese population: a meta-analysis based on 18 case-control studies.
    Genetic testing and molecular biomarkers, 2014, Volume: 18, Issue:6

    Topics: Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke

2014
A polymorphism (-455G>A) in the β-fibrinogen gene is associated with an increased risk of cerebral infarction in the Chinese population: A meta-analysis.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:2

    Topics: Asian People; Cerebral Infarction; China; Fibrinogen; Genetic Heterogeneity; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Publication Bias; Risk Factors

2015
Association between the FGB gene polymorphism and ischemic stroke: a meta-analysis.
    Genetics and molecular research : GMR, 2015, Mar-06, Volume: 14, Issue:1

    Topics: Asian People; Case-Control Studies; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Risk Factors; Stroke

2015
Effect of the -148C/T, 448G/A, and -854G/A Polymorphisms of the β-Fibrinogen Gene on the Risk of Ischemic Stroke in Chinese Population.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2015, Volume: 24, Issue:7

    Topics: Asian People; Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Odds Ratio; Phenotype; Polymorphism, Genetic; Risk Factors; Stroke

2015
Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:5

    Topics: Adult; Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; DNA Mutational Analysis; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Heterozygote; Humans; Mutation, Missense; Phenotype

2017
Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 26, Issue:1

    Topics: Apolipoproteins E; Asian People; Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Peptidyl-Dipeptidase A; Periodicals as Topic; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Publication Bias; Risk Assessment; Risk Factors; Stroke

2008
[Fibrinogen genes polymorphism in patients with ischemic stroke].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:4

    Topics: Brain Ischemia; DNA; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic

2008
Association of beta-fibrinogen gene -148C/T and -455G/A polymorphisms and coronary artery disease in Chinese population: a meta analysis.
    Science in China. Series C, Life sciences, 2008, Volume: 51, Issue:9

    Topics: Asian People; Coronary Artery Disease; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Protein Isoforms

2008
Markers of early disease and prognosis in COPD.
    International journal of chronic obstructive pulmonary disease, 2009, Volume: 4

    Topics: alpha 1-Antitrypsin Deficiency; Biomarkers; C-Reactive Protein; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Denmark; Early Diagnosis; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Hospitalization; Humans; Kaplan-Meier Estimate; Mannose-Binding Lectin; Odds Ratio; Phenotype; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Registries; Risk Assessment; Risk Factors; Severity of Illness Index

2009
The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:2

    Topics: Case-Control Studies; Factor V; Factor XIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Venous Thromboembolism

2009
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
    Immunological reviews, 2010, Volume: 233, Issue:1

    Topics: Animals; Antibody Specificity; Arthritis, Rheumatoid; Autoantibodies; Autoimmunity; Citrulline; Collagen Type II; Epitopes; Extracellular Matrix Proteins; Fibrinogen; Genetic Predisposition to Disease; Humans; Periodontitis; Phosphopyruvate Hydratase; Porphyromonas gingivalis; Protein Conformation; Protein Processing, Post-Translational; Risk Factors; Smoking; Vimentin

2010
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.
    BMC ophthalmology, 2010, Dec-13, Volume: 10

    Topics: Aging; Cardiovascular Diseases; Cataract Extraction; Diabetes Complications; Evidence-Based Medicine; Eye Color; Fibrinogen; Genetic Predisposition to Disease; Humans; Macular Degeneration; Obesity; Odds Ratio; Racial Groups; Risk; Risk Factors; Sex Factors; Smoking

2010
Venous thromboembolism: implications for gene-based diagnosis and technology development.
    Expert review of molecular diagnostics, 2002, Volume: 2, Issue:6

    Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis

2002
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
    Wiener klinische Wochenschrift, 2003, Aug-14, Volume: 115, Issue:13-14

    Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis

2003
Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?
    QJM : monthly journal of the Association of Physicians, 2004, Volume: 97, Issue:3

    Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors

2004
Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:10

    Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors; Thrombosis

2005
A meta-analysis of relationship between beta-fibrinogen gene -148C/T polymorphism and susceptibility to cerebral infarction in Han Chinese.
    Chinese medical journal, 2007, Jul-05, Volume: 120, Issue:13

    Topics: Cerebral Infarction; China; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic

2007
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: 3' Untranslated Regions; Arterial Occlusive Diseases; Blood Coagulation Factors; Factor V; Factor VII; Factor XIII; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Hemostasis; Humans; Hyperhomocysteinemia; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Point Mutation; Polymorphism, Genetic; Prothrombin; Receptors, Cell Surface; Risk Factors; Sequence Deletion; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis

2000
Predisposing genes, high-risk environments and coronary artery disease: LPL and fibrinogen as examples.
    World review of nutrition and dietetics, 2001, Volume: 89

    Topics: Coronary Artery Disease; Environment; Exercise; Fibrinogen; Genetic Predisposition to Disease; Homeostasis; Humans; Life Style; Lipoprotein Lipase; Obesity; Risk Factors; Triglycerides

2001
Genes encoding fibrinogen and cardiovascular risk.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:5

    Topics: Cardiovascular Diseases; Environment; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk Factors

2001
Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.
    Chest, 2002, Volume: 121, Issue:3

    Topics: Blood Coagulation Factors; Blood Platelets; Coronary Disease; Estrogen Replacement Therapy; Factor V; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Plasminogen Activator Inhibitor 1; Point Mutation; Polymorphism, Genetic; Postmenopause; Prothrombin; Thrombosis

2002
Possibilities of DNA analysis for the detection of predisposition to thrombotic disease.
    Annals of the New York Academy of Sciences, 1992, Dec-04, Volume: 667

    Topics: Biomarkers; DNA; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Plasminogen Activator Inhibitor 1; Thrombosis

1992
Hereditary disorders predisposing to thrombosis.
    Progress in hemostasis and thrombosis, 1986, Volume: 8

    Topics: Antithrombin III; Antithrombin III Deficiency; Blood Coagulation; Blood Proteins; Complement C4; Complement C4b; Disease Susceptibility; Enzyme Activation; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glycoproteins; Humans; Pedigree; Plasminogen; Protein Binding; Protein C; Protein C Deficiency; Protein C Inhibitor; Protein S; Receptors, Cell Surface; Receptors, Thrombin; Thrombosis

1986

Trials

4 trial(s) available for fibrinogen and Genetic Predisposition

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2012, Dec-15, Volume: 186, Issue:12

    Topics: C-Reactive Protein; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Quantitative Trait Loci; Tumor Necrosis Factor-alpha; Uteroglobin

2012
Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.
    Thrombosis research, 2003, Jun-15, Volume: 110, Issue:5-6

    Topics: Adult; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Hypertension; Male; Phenotype; Plasminogen Activator Inhibitor 1; Poland; Risk Assessment; Risk Factors; Smoking; Tissue Plasminogen Activator

2003
Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
    Atherosclerosis, 2002, Volume: 163, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Apolipoprotein C-III; Apolipoproteins C; Arterial Occlusive Diseases; Base Sequence; Bezafibrate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Hypolipidemic Agents; Male; Middle Aged; Molecular Sequence Data; Peripheral Vascular Diseases; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Reference Values; Sensitivity and Specificity; Treatment Outcome

2002

Other Studies

186 other study(ies) available for fibrinogen and Genetic Predisposition

ArticleYear
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case-control study.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:4

    Topics: Case-Control Studies; Fibrinogen; Genetic Predisposition to Disease; Hemostatics; Humans; Multiple Sclerosis; Polymorphism, Single Nucleotide

2022
Structural and Functional Characterization of Four Novel Fibrinogen Mutations in
    International journal of molecular sciences, 2022, Jan-10, Volume: 23, Issue:2

    Topics: Adolescent; Afibrinogenemia; Aged; Blood Coagulation; Blood Coagulation Tests; DNA Mutational Analysis; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Infant, Newborn; Male; Middle Aged; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship

2022
Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway.
    Cell death & disease, 2022, 02-08, Volume: 13, Issue:2

    Topics: Animals; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP2E1; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Liver Neoplasms; Mice; Polymorphism, Single Nucleotide; Proteomics; STAT4 Transcription Factor

2022
Functional analysis of rare genetic variants in complement factor I in advanced age-related macular degeneration.
    Human molecular genetics, 2022, 10-28, Volume: 31, Issue:21

    Topics: Complement Factor I; Fibrinogen; Genetic Predisposition to Disease; Heterozygote; Humans; Macular Degeneration; Polymorphism, Single Nucleotide

2022
A variant rs6214 within IGF-1 confers risk for ulcerative colitis in Chinese Han populations.
    Functional & integrative genomics, 2022, Dec-15, Volume: 23, Issue:1

    Topics: Case-Control Studies; Colitis, Ulcerative; East Asian People; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Insulin; Insulin-Like Growth Factor I; MicroRNAs; Polymorphism, Single Nucleotide; Risk

2022
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop).
    Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:1

    Topics: Afibrinogenemia; Anticoagulants; Blood Coagulation Tests; Codon, Nonsense; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Middle Aged; Recurrence; Thrombelastography; Venous Thrombosis; Warfarin

2020
Congenital structural and functional fibrinogen disorders: a primer for internists.
    Polish archives of internal medicine, 2019, 12-23, Volume: 129, Issue:12

    Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Middle Aged; Poland; Thrombosis; Young Adult

2019
Relationship between fibrinogen level and its regulatory gene with Alzheimer's disease and vascular dementia.
    The Journal of international medical research, 2020, Volume: 48, Issue:2

    Topics: Alzheimer Disease; Dementia, Vascular; Fibrinogen; Genes, Regulator; Genetic Predisposition to Disease; Humans

2020
Correlations Between the Genetic Variations in the
    Journal of athletic training, 2020, Volume: 55, Issue:5

    Topics: Adult; Anterior Cruciate Ligament Injuries; Asian People; Case-Control Studies; China; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type V; Collagen Type XII; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors

2020
Effect of rare coding variants in the CFI gene on Factor I expression levels.
    Human molecular genetics, 2020, 08-11, Volume: 29, Issue:14

    Topics: Aged; Aged, 80 and over; Alleles; Atypical Hemolytic Uremic Syndrome; Complement Factor I; Female; Fibrinogen; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Macular Degeneration; Male; Middle Aged; Polymorphism, Single Nucleotide

2020
Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
    International journal of laboratory hematology, 2020, Volume: 42, Issue:5

    Topics: Adolescent; Afibrinogenemia; Alleles; Amino Acid Substitution; Child; Child, Preschool; Female; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Humans; Hydrogen Bonding; Infant; Infant, Newborn; Iran; Male; Molecular Diagnostic Techniques; Molecular Dynamics Simulation; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship

2020
Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
    Journal of autoimmunity, 2021, Volume: 116

    Topics: Alleles; Amino Acid Sequence; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Binding, Competitive; Citrullination; Epitopes; Fibrinogen; Genetic Predisposition to Disease; Genotype; HLA-DRB1 Chains; Humans; Peptides; Peptides, Cyclic; Protein Binding; Protein-Arginine Deiminase Type 4

2021
Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
    Neurobiology of aging, 2021, Volume: 98

    Topics: Alzheimer Disease; Apolipoprotein E4; Biomarkers; C-Reactive Protein; Cerebral Small Vessel Diseases; Cognition; Dementia; Disease Progression; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Healthy Aging; Heterozygote; Humans; Inflammasomes; Male; Middle Aged; Risk; White Matter

2021
An association between fibrinogen gene polymorphisms and diabetic peripheral neuropathy in young patients with type 1 diabetes.
    Molecular biology reports, 2021, Volume: 48, Issue:5

    Topics: Adolescent; Adult; Alleles; Case-Control Studies; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Polymorphism, Single Nucleotide; Risk Factors; Slovakia; Young Adult

2021
MMP-10 rs17435959 Polymorphism is Associated with the Formation and Stability of Carotid Atherosclerosis Plaque: A Case-Control Study.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Matrix Metalloproteinase 10; Middle Aged; Phenotype; Plaque, Atherosclerotic; Polymorphism, Single Nucleotide; Prognosis; Risk Assessment; Risk Factors; Rupture, Spontaneous

2021
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:7

    Topics: ADAMTS13 Protein; Albuminuria; Animals; Cell Proliferation; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Extracellular Matrix; Fibrinogen; Genetic Predisposition to Disease; Kidney Glomerulus; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoprotein IIb; Streptozocin; Thrombosis; Urea; von Willebrand Factor

2017
The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura.
    Journal of receptor and signal transduction research, 2017, Volume: 37, Issue:5

    Topics: C-Reactive Protein; Calcitonin; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Migraine Disorders; Migraine with Aura; Neurogenic Inflammation; Receptors, Urokinase Plasminogen Activator

2017
Hypofibrinogenaemia associated with novel Aα126Val→Asp mutation in the fibrinogen coiled coil.
    Thrombosis and haemostasis, 2017, 10-05, Volume: 117, Issue:10

    Topics: Afibrinogenemia; Blood Coagulation; Child, Preschool; Fathers; Fibrinogen; Gene Expression; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Mass Spectrometry; Mutation; Pedigree; Polymorphism, Genetic

2017
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:1

    Topics: ABO Blood-Group System; Aged; Body Height; Case-Control Studies; Factor IX; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Norway; Phenotype; Polymorphism, Single Nucleotide; Prospective Studies; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism

2018
A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
    International journal of molecular sciences, 2017, Nov-20, Volume: 18, Issue:11

    Topics: Afibrinogenemia; Animals; Child, Preschool; CHO Cells; Cricetulus; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Mutation; Recombinant Proteins; Sequence Analysis, DNA

2017
Research on the correlation between the fibrinogen β and attack of pediatric pneumonia.
    European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:4 Suppl

    Topics: Alleles; C-Reactive Protein; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant, Newborn; Interleukin-6; Male; Odds Ratio; Pneumonia; Polymorphism, Single Nucleotide; Protein Subunits

2017
The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA
    Scientific reports, 2017, 12-13, Volume: 7, Issue:1

    Topics: 5-Lipoxygenase-Activating Proteins; Aged; Atrial Fibrillation; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Intracranial Embolism; Male; Matrix Metalloproteinase 9; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Risk Assessment; Stroke

2017
Venous thromboembolism risk associated with ABO, F11 and FGG loci.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2018, Volume: 29, Issue:6

    Topics: Adolescent; Adult; Factor XI; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Portugal; Venous Thromboembolism; Young Adult

2018
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
    Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:8

    Topics: ABO Blood-Group System; Adult; Aged; Case-Control Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Pedigree; Polymorphism, Single Nucleotide; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism

2019
Association of the -262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:1

    Topics: Aged; C-Reactive Protein; Case-Control Studies; Catalase; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Glutathione Peroxidase; Humans; Hypertension; Male; Middle Aged; NADPH Oxidases; Oxidative Stress; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Slovenia

2014
Association between two functional fibrinogen-related polymorphisms and ischemic stroke: a case-control study.
    Genetic testing and molecular biomarkers, 2013, Volume: 17, Issue:11

    Topics: Aged; Asian People; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Stroke

2013
The association between thrombophilic gene mutations and recurrent pregnancy loss.
    Journal of assisted reproduction and genetics, 2013, Volume: 30, Issue:10

    Topics: Abortion, Habitual; Adult; Factor V; Factor VII; Factor VIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Integrin alpha2; Mutation; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pregnancy; Prothrombin; Risk Factors; Thrombophilia; Young Adult

2013
Identification of genetic contribution to ischemic stroke by screening of single nucleotide polymorphisms in stroke patients by using a case control study design.
    BMC neurology, 2013, Oct-03, Volume: 13

    Topics: Apolipoproteins E; Brain Ischemia; Case-Control Studies; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Stroke

2013
Association of the FGA and SLC6A4 genes with autistic spectrum disorder in a Korean population.
    Neuropsychobiology, 2013, Volume: 68, Issue:4

    Topics: Adolescent; Adult; Asian People; Autistic Disorder; Case-Control Studies; Epistasis, Genetic; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Phenotype; Polymorphism, Single Nucleotide; Serotonin Plasma Membrane Transport Proteins; Young Adult

2013
Impact of -455G/a polymorphism of the β-fibrinogen gene on platelet aggregation in patients with acute coronary syndrome.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2014, Volume: 20, Issue:3

    Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Assessment; Ticlopidine

2014
Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
    Journal of clinical laboratory analysis, 2013, Volume: 27, Issue:6

    Topics: Abortion, Habitual; Adult; Case-Control Studies; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Odds Ratio; Polymorphism, Genetic; Risk Factors

2013
Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure.
    The Journal of thoracic and cardiovascular surgery, 2014, Volume: 148, Issue:2

    Topics: Adult; Aged; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Creatinine; Female; Fibrinogen; Gene Expression Profiling; Genetic Predisposition to Disease; Genome-Wide Association Study; Glutathione Transferase; Graft Occlusion, Vascular; Humans; Lipoproteins, HDL; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Treatment Failure; Vascular Patency

2014
Positive association of MMP 14 gene polymorphism with vulnerable carotid plaque formation in a Han Chinese population.
    Scandinavian journal of clinical and laboratory investigation, 2014, Volume: 74, Issue:3

    Topics: Age Factors; Aged; Asian People; Atherosclerosis; Biomarkers; Carotid Arteries; Cerebral Infarction; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Male; Matrix Metalloproteinase 14; Middle Aged; Plaque, Atherosclerotic; Polymorphism, Genetic; Risk Factors

2014
Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM.
    Human molecular genetics, 2014, Aug-01, Volume: 23, Issue:15

    Topics: Alleles; Antigens, Nuclear; CD11b Antigen; Chromatin; DNA-Binding Proteins; Female; Fibrinogen; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Humans; Ku Autoantigen; Lupus Erythematosus, Systemic; Male; Monocytes; NF-kappa B p50 Subunit; Odds Ratio; Polymorphism, Genetic; Protein Binding; Racial Groups; Risk; RNA, Messenger; Trans-Activators; Transcription, Genetic; Vitronectin

2014
The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations.
    Neurologia i neurochirurgia polska, 2014, Volume: 48, Issue:2

    Topics: Aged; Cerebral Hemorrhage; Female; Fibrinogen; Genes, Dominant; Genetic Predisposition to Disease; Genotype; Greece; Humans; Male; Middle Aged; Poland; Polymorphism, Genetic; Regression Analysis; Risk; Stroke

2014
Congenital dysfibrinogenemia coincidentally diagnosed at the onset of chronic myelogenous leukemia.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:5

    Topics: Adult; Afibrinogenemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mutation

2014
Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort.
    BMC neurology, 2014, Jun-22, Volume: 14

    Topics: Aged; Aged, 80 and over; Alleles; Cohort Studies; Female; Fibrinogen; Finland; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Stroke

2014
Functionally compromised FGG variant (γ320Asp→Glu) expressed at low level in plasma fibrinogen.
    Thrombosis research, 2014, Volume: 134, Issue:3

    Topics: Afibrinogenemia; DNA Mutational Analysis; Exons; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship; Young Adult

2014
Is there a significant lower genetic susceptibility to venous thrombosis in the Basques?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:6

    Topics: ABO Blood-Group System; Alleles; Ethnicity; Factor V; Factor XI; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Spain; Venous Thrombosis; von Willebrand Factor

2014
Prevalence of thrombophilic genetic factors among patients with retinitis pigmentosa.
    Retina (Philadelphia, Pa.), 2014, Volume: 34, Issue:10

    Topics: Adult; DNA Mutational Analysis; Factor V; Factor XIIIa; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Prevalence; Receptors, Tumor Necrosis Factor, Type II; Retinitis Pigmentosa; Risk Factors; Thrombophilia; Young Adult

2014
In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:11

    Topics: Adult; Afibrinogenemia; Cells, Cultured; Fibrinogen; Gene Deletion; Gene Expression Regulation; Genetic Predisposition to Disease; Genetic Therapy; Genetic Vectors; Hepatocytes; Homozygote; Humans; Lentivirus; Liver Transplantation; Male; Phenotype; Transduction, Genetic

2014
Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
    Thrombosis and haemostasis, 2015, Volume: 113, Issue:3

    Topics: Adult; Afibrinogenemia; Animals; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; Chlorocebus aethiops; COS Cells; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; HeLa Cells; Heterozygote; Homozygote; Humans; Male; Middle Aged; Mutation; Phenotype; Transfection; Young Adult

2015
Analysis of risk factors of ST-segment elevation myocardial infarction in young patients.
    BMC cardiovascular disorders, 2014, Dec-09, Volume: 14

    Topics: Adult; Age Factors; Aged; Biomarkers; Female; Fibrinogen; Genetic Predisposition to Disease; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Sex Factors; Smoking

2014
Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
    Thrombosis and haemostasis, 2015, Volume: 113, Issue:4

    Topics: Afibrinogenemia; Blood Coagulation Tests; Blood Loss, Surgical; Disulfides; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Humans; Middle Aged; Mutation; N-Acetylneuraminic Acid; Phenotype; Postoperative Hemorrhage; Protein Conformation; Structure-Activity Relationship

2015
[Modern methods of diagnosis of thrombophylic states and complex treatment of patients with thrombotic complications of severe forms of varicose disease].
    Klinichna khirurhiia, 2014, Issue:11

    Topics: Anticoagulants; Factor V; Factor VII; Factor XII; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Integrin alpha2; Integrin beta3; Leg; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Varicose Veins; Venous Thrombosis

2014
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Molecular immunology, 2015, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Atypical Hemolytic Uremic Syndrome; Base Sequence; Binding Sites; Child; Complement C3; Complement Factor H; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Membrane Cofactor Protein; Models, Molecular; Molecular Sequence Data; Mutation; Protein Binding; Protein Structure, Tertiary; Proteolysis; Recombinant Proteins; Severity of Illness Index

2015
Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
    Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13, Issue:8

    Topics: Afibrinogenemia; Amino Acid Sequence; Child, Preschool; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Heterozygote; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Models, Molecular; Molecular Sequence Data; Mutation, Missense; Phenotype; Protein Conformation; Structure-Activity Relationship

2015
BRCA2 gene mutations and coagulation-associated biomarkers.
    Thrombosis and haemostasis, 2016, Volume: 115, Issue:2

    Topics: Adult; alpha 1-Antitrypsin; Binding Sites; Biomarkers; Blood Coagulation; BRCA2 Protein; Breast Neoplasms; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Haptoglobins; Heterozygote; Humans; Middle Aged; Mutation; P-Selectin; Platelet Factor 4; Rad51 Recombinase; Transferrin

2016
Novel point mutation in fibrinogen (Innsbruck; BβArg44Gly). Phenotypic differences compared to another mutation (fibrinogen Nijmegen) at the same position.
    Hamostaseologie, 2015, Volume: 35 Suppl 1

    Topics: Adolescent; Female; Fibrinogen; Genetic Predisposition to Disease; Hemorrhage; Humans; Phenotype; Point Mutation; Polymorphism, Single Nucleotide

2015
Multiple thrombophilic single nucleotide polymorphisms lack a significant effect on outcomes in fresh IVF cycles: an analysis of 1717 patients.
    Journal of assisted reproduction and genetics, 2016, Volume: 33, Issue:1

    Topics: Adult; Antigens, Human Platelet; Embryo Implantation; Factor V; Factor XIII; Female; Fertilization in Vitro; Fibrinogen; Genetic Predisposition to Disease; Humans; Infertility; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Outcome; Prothrombin; Thrombophilia

2016
Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke.
    Neurology, 2016, Jan-26, Volume: 86, Issue:4

    Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Gene Expression; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Middle Aged; Oxidoreductases; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Recurrence; Stroke

2016
Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
    Neuromolecular medicine, 2016, Volume: 18, Issue:2

    Topics: Blood Coagulation Factors; Blood Platelets; Brain Ischemia; Factor V; Factor XIIIa; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Retrospective Studies; Risk Factors; Stroke; Thrombophilia

2016
Correlating blood levels of 8-hydroxydeoxyguanosine to hOGG1 genotypes and the incidence of ischemic cardiomyopathy.
    The Kaohsiung journal of medical sciences, 2016, Volume: 32, Issue:5

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; C-Reactive Protein; Cardiomyopathies; Case-Control Studies; Deoxyguanosine; DNA Glycosylases; Electrophoresis, Agar Gel; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Incidence; Lipids; Male; Middle Aged; Myocardial Ischemia; Risk Factors

2016
[Association between the C46T polymorphism of coagulation factor Ⅻ gene and the involvement of factor Ⅻ activity in patients with unexplained recurrent spontaneous abortion].
    Zhonghua fu chan ke za zhi, 2016, Aug-25, Volume: 51, Issue:8

    Topics: Abortion, Habitual; Abortion, Spontaneous; Alleles; Asian People; Case-Control Studies; China; Factor XII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Infertility; Polymorphism, Genetic; Pregnancy

2016
A novel missense mutation in the FGB gene (p.Gly302Arg) leading to afibrinogenemia. Predicted structure and function consequences.
    Hamostaseologie, 2016, Nov-08, Volume: 36, Issue:Suppl. 2

    Topics: Adult; Afibrinogenemia; Base Sequence; Codon, Nonsense; Diagnosis, Differential; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Molecular Sequence Data; Rare Diseases; Structure-Activity Relationship

2016
Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.
    International journal of legal medicine, 2017, Volume: 131, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Factor V; Factor XIII; Female; Fibrinogen; Formaldehyde; Genetic Predisposition to Disease; Glucuronidase; Heterozygote; Humans; Lipoproteins; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Paraffin Embedding; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Polymorphism, Genetic; Prothrombin; Pulmonary Embolism; Thrombophilia; Venous Thromboembolism

2017
A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia.
    Disease markers, 2017, Volume: 2017

    Topics: Adult; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Linkage Disequilibrium; Male; Polymorphism, Single Nucleotide; Schizophrenia; Sequence Analysis, DNA; Young Adult

2017
Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:5

    Topics: Animals; Antithrombin III; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Diet, Western; Disease Models, Animal; Female; Fibrinogen; Genetic Predisposition to Disease; Liver; Mice, Inbred C57BL; Mice, Knockout; Peptide Hydrolases; Phenotype; Plaque, Atherosclerotic; Protein C; RNA Interference; Thrombosis

2017
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome.
    Blood, 2008, Dec-01, Volume: 112, Issue:12

    Topics: Adult; Complement Factor H; Complement System Proteins; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Gestational Age; HELLP Syndrome; Humans; Membrane Cofactor Protein; Mutation, Missense; Pregnancy; Risk Factors; Young Adult

2008
Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:2

    Topics: Aged; Cerebral Hemorrhage; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Peptide Fragments; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke

2008
Linkage study of fibrinogen levels: the Strong Heart Family Study.
    BMC medical genetics, 2008, Aug-12, Volume: 9

    Topics: Adult; Arizona; Atherosclerosis; Chromosome Mapping; Cohort Studies; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Humans; Indians, North American; Linear Models; Lod Score; Male; Middle Aged; North Dakota; Oklahoma; Risk Factors; South Dakota

2008
Fibrinogen genes modify the fibrinogen response to ambient particulate matter.
    American journal of respiratory and critical care medicine, 2009, Mar-15, Volume: 179, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Environmental Exposure; Europe; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Urban Population

2009
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:2

    Topics: Adult; Antiphospholipid Syndrome; Case-Control Studies; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Odds Ratio; Polymorphism, Genetic; Protein Subunits; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation; Valine

2009
Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: results from the MONICA/KORA study.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:2

    Topics: Adult; Aged; Blood Pressure; Cross-Sectional Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Haplotypes; Health Surveys; Humans; Hypertension; Male; Middle Aged; Multigene Family; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Sex Factors; Young Adult

2009
[Genetic polymorphism and risk of arterial thrombosis in patients with atrial fibrillation].
    Klinicheskaia meditsina, 2008, Volume: 86, Issue:12

    Topics: Atrial Fibrillation; Brain Ischemia; Coronary Thrombosis; DNA; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Russia

2008
Breathe deeply into your genes!: genetic variants and air pollution effects.
    American journal of respiratory and critical care medicine, 2009, Mar-15, Volume: 179, Issue:6

    Topics: Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Urban Population

2009
[The beta-fibrinogen gene polymorphism, fibrinogen level and platelet aggregation in patients with ischemic stroke].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: Suppl 23

    Topics: Alleles; Brain Ischemia; DNA; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Retrospective Studies

2008
Fibrinogen gene polymorphism (Bbeta-148C/T) in Uygur patients with cerebral infarction.
    Neurological research, 2009, Volume: 31, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cerebral Infarction; China; DNA Mutational Analysis; Ethnicity; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Restriction Fragment Length

2009
Fibrinogen, genes, and arterial stiffness.
    Journal of hypertension, 2009, Volume: 27, Issue:7

    Topics: Arteries; Compliance; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male

2009
Genetic cardiovascular risk factors and age-related macular degeneration.
    Acta ophthalmologica, 2011, Volume: 89, Issue:4

    Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Macular Degeneration; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Single-Blind Method; White People

2011
A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2010, Volume: 63, Issue:2

    Topics: Abortion, Habitual; Adolescent; Adult; Apolipoproteins B; Apolipoproteins E; Case-Control Studies; Factor V; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; Integrin beta3; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Prothrombin; Thrombophilia; Turkey; Young Adult

2010
Common coding variants of the HNF1A gene are associated with multiple cardiovascular risk phenotypes in community-based samples of younger and older European-American adults: the Coronary Artery Risk Development in Young Adults Study and The Cardiovascula
    Circulation. Cardiovascular genetics, 2009, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Female; Fibrinogen; gamma-Glutamyltransferase; Genetic Predisposition to Disease; Genotype; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; White People

2009
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.
    Annals of human genetics, 2010, Volume: 74, Issue:1

    Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Interleukin-6; Male; Models, Biological; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk; Stroke

2010
A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men.
    Thrombosis and haemostasis, 2010, Volume: 103, Issue:4

    Topics: Amino Acid Substitution; Asian People; Biomarkers; Blood Pressure; Case-Control Studies; China; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Hypertension; Linear Models; Linkage Disequilibrium; Logistic Models; Male; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Prevalence; Risk Assessment; Risk Factors; Sex Factors; Time Factors

2010
-94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:9

    Topics: Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; I-kappa B Proteins; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Polymorphism, Genetic

2011
Does the progeny of premature ischemic stroke sufferers need intensive interest of physicians oriented toward primary prevention? A pilot study.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2010, Volume: 17, Issue:6

    Topics: Adult; Age of Onset; Analysis of Variance; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Homocysteine; Humans; Lipids; Logistic Models; Male; Odds Ratio; Pedigree; Phenotype; Pilot Projects; Poland; Primary Prevention; Risk Assessment; Risk Factors; Stroke; Young Adult

2010
[Negative association of FGA gene 128C/G polymorphism with cerebral infarction and its effect on plasma fibrinogen in Hunan Hans].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2010, Volume: 27, Issue:3

    Topics: Aged; Asian People; Cerebral Infarction; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length

2010
[Relationship between fibrinogen Bß-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2010, Volume: 12, Issue:7

    Topics: Child, Preschool; Coronary Artery Disease; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Polymorphism, Genetic

2010
Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:10

    Topics: Afibrinogenemia; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Coagulation; Child, Preschool; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Genetic Predisposition to Disease; Humans; Inclusion Bodies; International Normalized Ratio; Liver; Liver Diseases; Male; Metabolism, Inborn Errors; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship

2010
Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.
    Human genetics, 2010, Volume: 128, Issue:4

    Topics: 3' Untranslated Regions; Adult; Aged; Blotting, Western; Chronic Disease; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Luciferases; Male; MicroRNAs; Middle Aged; Mutation; Polymorphism, Genetic; Pulmonary Embolism; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection

2010
Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:5

    Topics: Adolescent; Adult; Afibrinogenemia; Animals; Blood Coagulation; Blood Coagulation Tests; Blotting, Western; Chlorocebus aethiops; COS Cells; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Predisposition to Disease; Heterozygote; Humans; Introns; Male; Microscopy, Electron, Scanning; Mutation; Pedigree; Phenotype; Protein Multimerization; RNA Splicing; Transfection; Young Adult

2010
Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:6

    Topics: Adult; Amino Acid Substitution; Arginine; Blood Coagulation; Blood Coagulation Disorders, Inherited; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Heredity; Humans; Middle Aged; Mutation; N-Acetylneuraminic Acid; Pedigree; Phenotype; Protein Conformation; Structure-Activity Relationship; Tryptophan

2010
Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).
    Blood, 2011, Jan-06, Volume: 117, Issue:1

    Topics: Adult; Aged; Black or African American; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; White People

2011
Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
    Platelets, 2011, Volume: 22, Issue:2

    Topics: Adult; Aged; Alleles; Blood Platelets; Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; India; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Polymorphism, Single Nucleotide; Risk Factors; Severity of Illness Index; Sex Factors; Tissue Plasminogen Activator

2011
Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:2

    Topics: Adult; Amino Acid Substitution; Blood Coagulation Disorders, Inherited; Codon; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Humans; Infant, Newborn; Mutation; Phenotype; Protein Conformation; Protein Folding; Structure-Activity Relationship

2011
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Thrombosis and haemostasis, 2011, Volume: 106, Issue:5

    Topics: Aged; Analysis of Variance; Austria; Biomarkers; Blood Coagulation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Venous Thromboembolism

2011
Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.
    Obesity (Silver Spring, Md.), 2012, Volume: 20, Issue:1

    Topics: Abdominal Fat; Absorptiometry, Photon; Adult; Blood Coagulation; Blood Coagulation Factors; Body Composition; Body Mass Index; C-Reactive Protein; Factor IX; Factor XI; Factor XII; Fasting; Fatty Liver; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glucose Clamp Technique; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Obesity; Plasminogen Activator Inhibitor 1; Thrombosis; Twins, Monozygotic

2012
Influence of matrix metalloproteinase-12 on fibrinogen level.
    Atherosclerosis, 2012, Volume: 220, Issue:2

    Topics: Animals; Atherosclerosis; England; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Italy; Linear Models; Linkage Disequilibrium; Logistic Models; Matrix Metalloproteinase 12; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors

2012
Fibrinogen polymorphisms associated with sporadic cerebral hemorrhage in a Chinese population.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:5

    Topics: Aged; Asian People; Case-Control Studies; Cerebral Hemorrhage; China; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide

2012
A genetic instrument for Mendelian randomization of fibrinogen.
    European journal of epidemiology, 2012, Volume: 27, Issue:4

    Topics: Alleles; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Multigene Family; Polymorphism, Single Nucleotide; Prospective Studies; Survival Analysis; United Kingdom

2012
Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis.
    Rheumatology international, 2013, Volume: 33, Issue:9

    Topics: Adult; Aged; Arthritis, Rheumatoid; Autoantibodies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Peptides, Cyclic; Plasminogen Inactivators; Polymorphism, Single Nucleotide; Prothrombin

2013
Multiple gene polymorphisms predisposing to the prothrombotic state in an adolescent with acute myocardial infarction.
    Cardiovascular journal of Africa, 2012, Apr-12, Volume: 23, Issue:3

    Topics: Adolescent; Anticoagulants; Aspirin; Cholesterol Ester Transfer Proteins; Clopidogrel; Coronary Angiography; Electrocardiography; Fibrinogen; Genetic Predisposition to Disease; Heparin; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombosis; Ticlopidine

2012
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
    Atherosclerosis, 2012, Volume: 223, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Analysis of Variance; Apolipoprotein E4; Biomarkers; Black or African American; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Inflammation; Inflammation Mediators; Phenotype; Phospholipases A2; Risk Assessment; Risk Factors; Serum Amyloid A Protein; Serum Amyloid P-Component; United States; White People

2012
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
    Annals of the rheumatic diseases, 2013, Volume: 72, Issue:5

    Topics: Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; Citrulline; Collagen Type II; Cross Reactions; Epitopes; Fibrinogen; Genetic Predisposition to Disease; Genotype; HLA-DRB1 Chains; Humans; Logistic Models; Peptides; Phosphopyruvate Hydratase; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Risk Factors; Seroepidemiologic Studies; Smoking; Sweden; Vimentin

2013
[Gene-determined hemocoagulation disease as a cause of ischemic stroke in children].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2011, Volume: 111, Issue:12 Pt 2

    Topics: Alleles; Blood Coagulation Disorders; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2; Male; Mutation; Plasminogen Activator Inhibitor 1; Stroke; Thrombosis

2011
Fibrinogen Gdansk: hypofibrinogenemia associated with a novel missense mutation in FGA (Ser112Pro).
    Thrombosis research, 2012, Volume: 130, Issue:3

    Topics: Adult; Afibrinogenemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Mutation, Missense

2012
[Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2012, Volume: 29, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; China; Factor VII; Factor XII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic

2012
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women.
    Gene, 2012, Oct-25, Volume: 508, Issue:2

    Topics: Alu Elements; Body Mass Index; Cardiovascular Diseases; Estrogen Receptor beta; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Middle Aged; Polymorphism, Genetic; Postmenopause; Prognosis; Risk Factors

2012
Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients.
    Cytokine, 2013, Volume: 61, Issue:1

    Topics: Adult; Age Factors; Biomarkers; Creatine Kinase, MB Form; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prothrombin; Troponin; Tumor Necrosis Factor-alpha; Young Adult

2013
Heterogeneity of platelet functional alterations in patients with filamin A mutations.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:1

    Topics: Blood Platelets; Blotting, Western; Cell Shape; Collagen; Contractile Proteins; Crotalid Venoms; Cytoskeleton; Dose-Response Relationship, Drug; Female; Fibrinogen; Filamins; Genetic Predisposition to Disease; Heterozygote; Humans; Lectins, C-Type; Microfilament Proteins; Muscular Dystrophies; Mutation; Phenotype; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Signal Transduction; Thrombocytopenia; Thrombosis; von Willebrand Factor

2013
Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Citrulline; Collagen Type II; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Fibrinogen; Freund's Adjuvant; Genetic Predisposition to Disease; Immunotherapy, Active; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Myelin Basic Protein; Protein Processing, Post-Translational; Proteins

2013
Thrombosis in association with a novel substitution (γ346Gly→Val) at an absolutely conserved site in the fibrinogen γ chain.
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:4

    Topics: Blood Coagulation; Blood Coagulation Tests; Conserved Sequence; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Mutation; Peptide Fragments; Phenotype; Venous Thrombosis; Young Adult

2013
Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas.
    Journal of neurology, 2002, Volume: 249, Issue:6

    Topics: Aged; Case-Control Studies; Central Nervous System Vascular Malformations; Cranial Sinuses; Factor V; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Protein C; Prothrombin; Risk Factors; Thrombophilia

2002
Fibrinogen and factor VII promoter polymorphisms in women with preeclampsia.
    Obstetrics and gynecology, 2002, Volume: 100, Issue:2

    Topics: Adult; Case-Control Studies; Factor VII; Female; Fibrinogen; Gene Expression; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Pre-Eclampsia; Pregnancy; Probability; Promoter Regions, Genetic; Reference Values; Retrospective Studies; Sensitivity and Specificity

2002
Fibrinogen--the key to familial CHD or just another shadow in Plato's allegory?
    European heart journal, 2002, Volume: 23, Issue:16

    Topics: Biomarkers; Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Prognosis; Risk Factors

2002
Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease.
    European heart journal, 2002, Volume: 23, Issue:16

    Topics: Adolescent; Adult; Age of Onset; Aged; Case-Control Studies; Coronary Disease; Factor VII; Fibrinogen; Genetic Predisposition to Disease; Humans; Linear Models; Male; Middle Aged; Risk Factors; von Willebrand Factor

2002
Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2002, Volume: 12, Issue:3

    Topics: Adult; Age Distribution; Analysis of Variance; Biomarkers; Blood Chemical Analysis; Blood Pressure Determination; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Probability; Reference Values; Risk Factors; Sensitivity and Specificity; Sex Distribution; Statistics, Nonparametric; Stroke; Thrombosis; von Willebrand Factor

2002
Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
    Blood, 2002, Dec-15, Volume: 100, Issue:13

    Topics: Adolescent; Afibrinogenemia; Base Sequence; Blood Coagulation Tests; Child, Preschool; Cloning, Molecular; Consanguinity; DNA Mutational Analysis; Fibrinogen; Genetic Predisposition to Disease; HeLa Cells; Hemorrhagic Disorders; Humans; Introns; Iran; Italy; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Pedigree; Protein Conformation; Reverse Transcriptase Polymerase Chain Reaction; RNA Splice Sites; RNA Splicing; Transcription, Genetic; Transfection

2002
Does plasma fibrinogen increase thrombotic tendency?
    European journal of clinical investigation, 2002, Volume: 32, Issue:10

    Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk; Venous Thrombosis

2002
G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis.
    European journal of clinical investigation, 2002, Volume: 32, Issue:10

    Topics: Alleles; Case-Control Studies; Fibrinogen; Genes, APC; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Polymorphism, Genetic; Risk Factors; Venous Thrombosis

2002
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Nov-26, Volume: 99, Issue:24

    Topics: Animals; Endomyocardial Fibrosis; Factor VII; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Hemophilia B; Hemorrhagic Disorders; Hemosiderin; Hemostasis; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Models, Biological; Muscle, Skeletal; Myocardium; Organ Specificity; Protein Structure, Tertiary; Recombinant Fusion Proteins; Thromboplastin; Ventricular Dysfunction, Left

2002
Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family.
    Blood, 2003, May-01, Volume: 101, Issue:9

    Topics: Abortion, Spontaneous; Afibrinogenemia; Amino Acid Sequence; Amniocentesis; Arabs; Codon; Codon, Nonsense; Consanguinity; DNA, Complementary; Female; Fetal Diseases; Fibrinogen; Genes, Recessive; Genetic Predisposition to Disease; Hemorrhagic Disorders; Humans; Infant, Newborn; Male; Molecular Sequence Data; Pedigree

2003
Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.
    Stroke, 2003, Volume: 34, Issue:4

    Topics: Aged; Alleles; Brain Infarction; Cerebral Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Stroke

2003
A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study.
    Thrombosis research, 2003, Apr-15, Volume: 110, Issue:1

    Topics: Adult; Arteriosclerosis; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 7; Cohort Studies; Coronary Disease; Diabetes Mellitus; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Genome, Human; Genotype; Humans; Hypertension; Lod Score; Male; Middle Aged; Obesity; Polymorphism, Restriction Fragment Length; Risk Factors

2003
Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.
    The American journal of cardiology, 2003, Sep-01, Volume: 92, Issue:5

    Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Coronary Artery Disease; Cytokines; Environmental Exposure; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Immunoglobulin A; Immunoglobulin G; Infections; Inflammation; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Prevalence; Prognosis; Risk Factors; Tumor Necrosis Factor-alpha

2003
Risk-factor profile in severe, generalized, obliterating vascular disease.
    Southern medical journal, 2004, Volume: 97, Issue:1

    Topics: Aged; Apolipoproteins E; Arteriosclerosis Obliterans; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polymorphism, Genetic; Risk Factors

2004
-455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2

    Topics: 3' Untranslated Regions; Abruptio Placentae; Adolescent; Adult; Alleles; Amino Acid Substitution; DNA Mutational Analysis; Ethnicity; Factor V; Female; Fetal Death; Fetal Growth Retardation; Fibrinogen; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Placental Circulation; Point Mutation; Polymorphism, Genetic; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prevalence; Prothrombin; Thrombophilia

2004
Beta-fibrinogen promoter -455 G/A (HaeIII) polymorphism prediction of plasma fibrinogen but not of ischemic cerebrovascular disease.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2004, Volume: 19, Issue:1

    Topics: Alleles; Cerebrovascular Disorders; Female; Fibrinogen; Genetic Predisposition to Disease; Homozygote; Humans; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Risk Factors

2004
Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Apolipoprotein A-I; Case-Control Studies; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Parents; Risk Factors; Sampling Studies; Siblings

2004
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:3

    Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Atrial Fibrillation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Inflammation; Interleukin-6; Male; P-Selectin; Polymorphism, Genetic; Thromboplastin

2004
Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study.
    American heart journal, 2004, Volume: 148, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Point Mutation; Polymorphism, Genetic; Serum Amyloid A Protein

2004
[Association of polymorphic marker G(-455)A of gene FGB with coronary artery disease].
    Genetika, 2004, Volume: 40, Issue:10

    Topics: Alleles; Coronary Disease; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Male; Moscow; Myocardial Infarction; Polymorphism, Single Nucleotide

2004
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:6

    Topics: Aged; Alleles; Body Mass Index; Case-Control Studies; Environment; Europe; Exons; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Interleukin-6; Introns; Male; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Risk; Smoking; Time Factors; Venous Thrombosis

2004
Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2004, Volume: 14, Issue:5

    Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Perindopril; Phenotype; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Treatment Outcome

2004
The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes.
    Folia biologica, 2004, Volume: 50, Issue:6

    Topics: Bacterial Proteins; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2beta1; Male; Myocardial Infarction; Polymorphism, Genetic; White People

2004
A genome search for genetic determinants that influence plasma fibrinogen levels.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Gene Expression Profiling; Genetic Predisposition to Disease; Genomics; Haplotypes; Humans; Infant; Linkage Disequilibrium; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Thrombosis

2005
Genetic and environmental origins of the association between birth weight and cardiovascular risk factors.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:6

    Topics: Birth Weight; Cardiovascular Diseases; Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Hypertension; Risk Factors; Twin Studies as Topic

2005
The effect of birth weight on clottable and intact fibrinogen levels: a twin study.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:6

    Topics: Adult; Birth Weight; Case-Control Studies; Databases, Factual; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Linear Models; Male; Middle Aged; Thrombophilia; Twins, Dizygotic; Twins, Monozygotic

2005
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:1

    Topics: Adult; Aged; Alleles; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Ethnicity; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Renal Dialysis; Risk; Smoking

2005
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
    Polskie Archiwum Medycyny Wewnetrznej, 2005, Volume: 113, Issue:2

    Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fibrinogen; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Lipoprotein(a); Male; Risk Factors; Stroke; Time Factors; Triglycerides; von Willebrand Factor

2005
[Correlation between fibrinogen polymorphisms and the type of cerebral infarction].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2005, Volume: 22, Issue:5

    Topics: Aged; Cerebral Infarction; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length

2005
Genetic risk factors for arterial thrombosis and inflammation.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Arteries; Factor V; Factor VIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Hemostasis; Humans; Inflammation; Myocardial Infarction; Risk Factors; Stroke; Thrombosis

2005
Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.
    Human genetics, 2006, Volume: 119, Issue:1-2

    Topics: Adult; Aged; Alleles; Cell Line, Tumor; DNA Mutational Analysis; Female; Fibrinogen; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Luciferases; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Protein Subunits; Recombinant Fusion Proteins; Taiwan; Thromboembolism; Venous Thrombosis

2006
Fibrinogen and CRP in Israeli families: genetic and environmental sources of concentrations and longitudinal changes.
    Atherosclerosis, 2006, Volume: 189, Issue:1

    Topics: Adult; Biomarkers; C-Reactive Protein; Environmental Exposure; Environmental Illness; Female; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Incidence; Israel; Male; Middle Aged; Phenotype; Retrospective Studies; Risk Factors

2006
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
    Journal of clinical pathology, 2006, Volume: 59, Issue:2

    Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A

2006
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:3

    Topics: Environment; Epistasis, Genetic; Factor XIII; Fibrin; Fibrinogen; Gels; Genetic Markers; Genetic Predisposition to Disease; Humans; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Porosity; Risk Factors

2006
Hypofibrinogenaemia resulting from novel single nucleotide deletion at codon Bbeta58 (3404del A) associated with thrombotic stroke in infancy.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:4

    Topics: Adolescent; Adult; Afibrinogenemia; Amino Acid Sequence; Base Sequence; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Molecular Sequence Data; Point Mutation; Stroke; Thrombosis

2006
[A linkage between beta-fibrinogen gene -148C/T polymorphism and cerebral infarction].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2006, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Asian People; Cerebral Infarction; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Stroke; Young Adult

2006
Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:6

    Topics: Aged; Base Sequence; Blood Proteins; Cardiovascular Diseases; Chromosome Mapping; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Hemostatics; Humans; Linkage Disequilibrium; Male; Middle Aged; Molecular Sequence Data; Multigene Family; Plasminogen Activators; Polymorphism, Single Nucleotide; Thrombosis

2006
Randomised by (your) god: robust inference from an observational study design.
    Journal of epidemiology and community health, 2006, Volume: 60, Issue:5

    Topics: Aged; Alcohol Drinking; Cardiovascular Diseases; Cholesterol; Epidemiologic Research Design; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Humans; Male; Middle Aged; Neural Tube Defects; Risk

2006
Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.
    Atherosclerosis, 2007, Volume: 191, Issue:2

    Topics: Adenine; Adult; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fasting; Female; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Genotype; Guanine; Homeostasis; Humans; Immunoenzyme Techniques; Insulin; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Reference Values; Risk Factors

2007
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Black or African American; Blood Coagulation Tests; Cardiovascular Diseases; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Immunoassay; Linkage Disequilibrium; Phenotype; Polymorphism, Single Nucleotide; Reproducibility of Results; White People

2006
[Study on the relationship between polymorphisms of susceptible genes in coagulation pathway related to pulmonary thromboembolism in Chinese Han population].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2006, Volume: 27, Issue:2

    Topics: Asian People; Case-Control Studies; China; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Pulmonary Embolism; Risk Factors

2006
[A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2006, Volume: 23, Issue:3

    Topics: Alleles; Brain Ischemia; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke

2006
Commentary: fibrinogen and coronary heart disease--test of causality by 'Mendelian' randomization by Keavney et al.
    International journal of epidemiology, 2006, Volume: 35, Issue:4

    Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Meta-Analysis as Topic; Polymorphism, Genetic; Risk Assessment

2006
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Thrombosis and haemostasis, 2006, Volume: 96, Issue:4

    Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Humans; Integrin alpha2; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Serine Endopeptidases; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis

2006
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Journal of medical genetics, 2007, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Complement C3; Complement C3 Nephritic Factor; Complement Factor H; Complement Pathway, Alternative; Female; Fibrinogen; Genetic Predisposition to Disease; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Hemolytic-Uremic Syndrome; Humans; Male; Membrane Cofactor Protein; Mesangial Cells; Middle Aged; Retrospective Studies; Risk Factors

2007
TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects.
    Human genetics, 2007, Volume: 121, Issue:1

    Topics: Aged; Aged, 80 and over; Arachidonate 5-Lipoxygenase; Carotid Stenosis; Case-Control Studies; DNA-Binding Proteins; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; I-kappa B Proteins; Inflammation; Interleukin-6; Longitudinal Studies; Male; Middle Aged; NF-KappaB Inhibitor alpha; Polymorphism, Single Nucleotide; Receptors, Interleukin-4

2007
Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:4

    Topics: Female; Fibrin; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Models, Genetic; Myocardial Infarction; Peptide Fragments; Polymorphism, Genetic; Protein Isoforms; Risk; Risk Factors; RNA, Messenger

2007
Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:2

    Topics: Aged; Aortic Diseases; Calcinosis; Carotid Artery Diseases; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors

2007
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Homozygote; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Introns; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Receptors, Interleukin-1 Type I; Receptors, Interleukin-1 Type II; Risk Assessment; Risk Factors; Venous Thrombosis

2007
The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
    Thrombosis research, 2007, Volume: 121, Issue:1

    Topics: Adult; Aged; Austria; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis

2007
Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:5

    Topics: Adolescent; Adult; Alleles; Cohort Studies; Cross-Sectional Studies; Epistasis, Genetic; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kidney Glomerulus; Logistic Models; Lupus Nephritis; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Thrombosis

2007
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:8

    Topics: Age of Onset; Child; Complement Factor H; Female; Fibrinogen; Genetic Predisposition to Disease; Hemolytic-Uremic Syndrome; Humans; Infant; Kidney Transplantation; Male; Membrane Cofactor Protein; Plasma; Point Mutation; Postoperative Complications; Prognosis; Risk Factors; Thrombosis; Treatment Outcome

2007
Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:10

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Activation; Vascular Surgical Procedures

2007
Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:3

    Topics: Adult; Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Models, Molecular; Mutation; Pedigree; Phenotype; Pregnancy; Protein Conformation

2007
Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:12

    Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Europe; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Metabolic Syndrome; Middle Aged; Nephelometry and Turbidimetry; Pedigree; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Time Factors

2007
Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:8

    Topics: Adult; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Predisposition to Disease; Genotype; Humans; Phenotype; Polymers; Polymorphism, Single Nucleotide

2007
Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:12

    Topics: Alleles; Antibodies, Anti-Idiotypic; Antibody Specificity; Arthritis, Rheumatoid; Citrulline; Cohort Studies; Epitopes; Fibrinogen; Genetic Predisposition to Disease; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Vimentin

2007
Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
    The European respiratory journal, 2008, Volume: 31, Issue:4

    Topics: Adult; Aged; Cohort Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Male; Middle Aged; Polymorphism, Single Nucleotide; Thromboembolism

2008
Cardiovascular risk factors in obese women and their first-degree relatives.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2007, Volume: 7, Issue:4

    Topics: Adult; Aged; Anthropometry; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Family; Female; Fibrinogen; Genetic Predisposition to Disease; Heart Rate; Humans; Insulin; Linear Models; Lipids; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; Turkey

2007
Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
    Human heredity, 2008, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Myocardial Ischemia; Parents; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Siblings

2008
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:2

    Topics: Age Factors; Aged; Black or African American; Brain Ischemia; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Stroke; United States; White People

2008
Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease.
    Translational research : the journal of laboratory and clinical medicine, 2008, Volume: 151, Issue:3

    Topics: Adult; Asian People; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation Mediators; Interleukin-6; Korea; Lipids; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Reference Values

2008
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:5

    Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Cohort Studies; DNA Mutational Analysis; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors

2008
Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease--the Indian Atherosclerosis Research Study.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:5

    Topics: Adult; Age of Onset; Aged; Asian People; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; DNA Mutational Analysis; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Haplotypes; Humans; India; Interleukin-6; Lod Score; Male; Middle Aged; Odds Ratio; Pedigree; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Quantitative Trait Loci; Risk Assessment; Risk Factors

2008
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation.
    Virchows Archiv : an international journal of pathology, 2008, Volume: 453, Issue:1

    Topics: Amyloidosis; Biopsy; Diagnosis, Differential; Exons; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Kidney; Male; Middle Aged; Mutation; Pedigree; White People

2008
Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:1

    Topics: Aged; Alleles; Asian People; Base Sequence; Body Mass Index; Coronary Disease; Diet; Disease Susceptibility; Estrogen Replacement Therapy; Female; Fibrinogen; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Habits; Humans; Japan; Male; Menopause; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Risk Factors; Triglycerides; United States; White People

1995
Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients.
    Thrombosis research, 1995, Feb-01, Volume: 77, Issue:3

    Topics: Alleles; Base Sequence; Coronary Disease; Fibrinogen; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Polymorphism, Restriction Fragment Length

1995
Fibrinogen plasma levels in an apparently healthy general population--relation to environmental and genetic determinants.
    Thrombosis and haemostasis, 1998, Volume: 80, Issue:5

    Topics: Adult; Age Factors; Aged; Alcohol Drinking; Alleles; Body Mass Index; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Italy; Life Style; Lipids; Male; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Reference Values; Risk Factors; Smoking

1998
[Comparative study of peripheral circulation, lipid metabolism and hemocoagulation in families with atherosclerosis and diabetes mellitus].
    Terapevticheskii arkhiv, 1998, Volume: 70, Issue:10

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Circulation; Blood Coagulation; Child; Cholesterol, HDL; Diabetes Mellitus; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Lipids; Male; Middle Aged; Triglycerides

1998
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
    Circulation, 1999, May-11, Volume: 99, Issue:18

    Topics: Amino Acid Substitution; Atrial Fibrillation; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Point Mutation; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Survival Analysis; Thromboembolism; Thrombophilia; Transglutaminases

1999
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:1

    Topics: Adult; Aged; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors

1999
Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes.
    Diabetologia, 1999, Volume: 42, Issue:10

    Topics: Age Factors; Alleles; Body Mass Index; China; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Risk Factors; Sex Factors; Smoking

1999
Contribution of the -455G/A polymorphism at the beta-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:5

    Topics: 5' Untranslated Regions; Adult; Comorbidity; Coronary Disease; Erythrocyte Aggregation; Female; Fibrinogen; Gene Expression Regulation; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Quebec; Smoking

1999
The Pl(A2) allele and cardiovascular disease: the pro(33) and con.
    The Journal of clinical investigation, 2000, Volume: 105, Issue:6

    Topics: Alleles; Amino Acid Substitution; Antigens, Human Platelet; Cardiovascular Diseases; Cell Adhesion Molecules; Clot Retraction; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Predisposition to Disease; Humans; Male; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Protein Isoforms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Risk Factors

2000
The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions.
    The Journal of clinical investigation, 2000, Volume: 105, Issue:6

    Topics: Actins; Alleles; Amino Acid Substitution; Animals; Antigens, Human Platelet; Biopolymers; Cell Adhesion Molecules; Cell Line; Cell Size; CHO Cells; Clot Retraction; Coronary Disease; Cricetinae; Cricetulus; Cytochalasin D; Cytoskeleton; Female; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Predisposition to Disease; Humans; Kidney; Male; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Protein Isoforms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Risk Factors; Signal Transduction

2000
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
    Journal of clinical epidemiology, 2000, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Black People; Case-Control Studies; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Regression Analysis; Risk Factors; United States; Venous Thrombosis

2000
Racial and genetic determinants of plasma factor XIII activity.
    Genetic epidemiology, 2000, Volume: 19, Issue:4

    Topics: Adult; Asian People; China; Coronary Disease; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Plasminogen; Polymorphism, Genetic; Risk Assessment; White People

2000
Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromsø study.
    Atherosclerosis, 2001, Feb-01, Volume: 154, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Life Style; Male; Middle Aged; Norway; Prevalence; Retrospective Studies; Risk Factors; Sex Characteristics; Sex Factors; Surveys and Questionnaires; Triglycerides; Tunica Intima; Ultrasonography

2001
Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H.
    Scandinavian journal of immunology, 2001, Volume: 53, Issue:6

    Topics: Adult; Bacterial Infections; Cell Migration Inhibition; Cells, Cultured; Child, Preschool; Coagulation Protein Disorders; Complement Activation; Complement C3; Complement C3b; Complement Factor H; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Immunoelectrophoresis, Two-Dimensional; Lupus Erythematosus, Systemic; Phagocytosis

2001
Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
    Circulation, 2001, Jul-10, Volume: 104, Issue:2

    Topics: Adenosine Diphosphate; Alleles; Antigens, Human Platelet; Cardiovascular Diseases; Epinephrine; Epitopes; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homozygote; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Vasoconstrictor Agents; von Willebrand Factor

2001
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.
    Annals of the New York Academy of Sciences, 2001, Volume: 936

    Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Diseases

2001
Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:8

    Topics: Adult; Age of Onset; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Insulin Resistance; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides

2001
Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese.
    Journal of medical genetics, 2001, Volume: 38, Issue:9

    Topics: Adult; Aged; Analysis of Variance; Asian People; China; Coronary Disease; Environment; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Risk Factors; Singapore; Smoking

2001
Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2001, Volume: 11 Suppl 5

    Topics: Adolescent; Adult; Brain Ischemia; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Regression Analysis; Risk Factors; Severity of Illness Index; Stroke; Uric Acid

2001